CRISPR Technology Market Synopsis

CRISPR Technology Market Size is Valued at USD 3.93 Billion in 2023, and is Projected to Reach USD 12.53 Billion by 2032, Growing at a CAGR of 15.60% From 2024-2032.

The CRISPR Technology Market can therefore be defined as the market encompassing business activities associated with the integration of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), new and advanced tool of genetic manipulations of cells and organisms. This market comprises devices tools, reagents and instruments that are related to CRISPR and that may be used in areas like medicine, agriculture, and research. This research shows that the rising need for breakthrough and enhanced genetic therapies and other development in genomic field is fueling the market for CRISPR technology.

• CRISPR Technology Market is most influenced by the shift in innovation in gene editing technologies. Precision genetic editing with minimal expenditure and high throughput has changed many a field with specific focus on molecular biology and therapeutic sciences. In addition, continued research into the use of CRISPR as medicine for genetic diseases, cancer, and viral diseases, make it probable that there will be a high demand for CRISPR tools and solutions.
• Further, the increasing awareness of the hopes and promises of agricultural biotechnology products, a concern that has extended to food security, has boosted the market for CRISPR technology. Given the fact that the world population is expected to continually grow in the foreseeable future, there is need to develop crop varieties that are stable to biotic stresses and pests, and diseases. Most recently, it has been deemed that the era of CRISPR technology will address the possibilities of improving the yield, nutritional value as well as rights of biotic and abiotic stresses, making it one of the leading technologies that propel the agricultural sector today.

CRISPR Technology Market Trend Analysis

The growing emphasis on ethical considerations.

• One of the key trends for the market of CRISPR Technologies is shift towards ethical concerns as well as the legal regulation of the application of gene editing. With progress towards realizing the technology several issues related to the possible abuse of the same, harms to the environment by using the same and modification of human germlines through the same are emerging the eyes of the regulatory authorities and the public. This trend is forcing stakeholders to ensure that ethics are followed in research and ensure that there is set standard policies in this area of CRISPR especially in the overall health and farming industries.
• One more important and increasing phenomenon is the growing interaction between universities and biotechnology enterprises. This means that the number of partnerships as well as collaborations is increasing due to the fact that different organizations want to benefit from each other’s expertise and capabilities in CRISPR technology. It has helped in the rise of one promising field to another that is helping intensification of the conversion of research discoveries into marketable products as well as increased diffusion of CRISPR solutions in numerous sectors.

Opportunities in the field of personalized medicine

• The opportunities can be observed mainly in the application of CRISPR Technology Market in the field of personalized medicine. Thus, as researchers investigate CRISPR for as a way to personalising medicines depending of the patient’s genes, the public has willingly embraced CRISPR as therapeutics and diagnostic tools. This trend not only has positive implications towards improving treatment efficacies but also by meeting needs for treatments of genetic disorders and cancers which collectively make the market very attractive for companies operating within it.
• However, the existing possibilities of expanding the use of CRISPR in agriculture show a very high growth perspective. The ever-growing concern with food security and the climate change that has recently characterized the earth’s climate sort CRISPR technology for the enhanced and development of crops to produce in unfavourable conditions. This market potential is likely to foster development of new solutions to challenges such as food security and environmental sustainability, thereby aligning firms to capture the market share in the transforming agriculture sector.

CRISPR Technology Market Segment Analysis:

CRISPR Technology Market Segmented on the basis of type, application, and end-users.

By Type, CRISPR Cas12 segment is expected to dominate the market during the forecast period

• The CRISPR technology can be categorized into three main types based on the Cas proteins they utilize: Cas9, Cas12, and Cas13. CRISPR Cas9 is the most common type; it provides defined snips to slice the DNA duplex, which may be deployed for gene altering in different species. Cas12 also has similar features as Cas9 but especially in cases where it is important the protein can recognize multiple sites the system is more advantageous. That is why CRISPR Cas13 stands out for its specific activity towards RNA and represents a prospect for RNA interference needed for therapeutic usage, viruses’ elimination, and other functions. The diferent kinds of CRISPR systems have their own technical benefits and are used across different spheres in medicine, agriculture and biotechnology, which makes this gene editing technique more helpful and useful across many industries.

By Application, Medical Applications segment held the largest share in 2024

• The CRISPR technology market is segmented by application into four primary categories: medical, agricultural, industrial and as sample source for research. These uses of CRISPR include gene therapy, disease modeling, enhanced gene editing, and general gene engineering for customized treatments where clients get to benefit depending on the type of gene disorder or a certain disease including cancer. While agricultural, applications aim at improving the quality of the crops including disease tolerance and crop yield which has led to creation of genetically modified organisms GMOs that are resistant to environmental shocks and Increases food availability. Crispr is also used in bio industries, including using it in enzyme and biofuel production to name but a few. Lastly, research applications entail the use of CRISPR as an efficient method of gene modification, and application in genetic and functional genome research, expedited scientific investigations that analyze the functions of genes across a diverse range of fields.

CRISPR Technology Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• North America is at present the largest market for CRISPR Technology, this due to the great research and development and a large investment in biotechnology, also the most encouraging regulatory environment. Because leading academic institutions as well as biotechnology companies are present in the United States, the growth and development of the CRISPR technique gains momentum. In addition, significant governmental and non-governmental funding propels research and development, as well as commercialisation of CRISPR-based goods and services, making the locus of the market the region.
• However, CRISPR adoption rate is rising across North America because of the healthcare and agriculture sectors’ frequent application of the technology. As the number of clinical trials and research projects that involve the use of CRISPR for therapeutic purposes continues to grow and with the continual improvement of agricultural biotechnology, North America will likely be able to respond well to the steadily rising demand for the solutions based on CRISPR. This is expected to be the case given that the region is most advanced in innovation and regulation of the technology that is the CRISPR.

Active Key Players in the CRISPR Technology Market

• CRISPR Therapeutics (Switzerland)
• Editas Medicine (United States)
• Intellia Therapeutics (United States)
• Caribou Biosciences (United States)
• Cellectis (France)
• MilliporeSigma (United States)
• Integrated DNA Technologies (United States)
• Takara Bio (Japan)
• Genomatix Software GmbH (Germany)
• Thermo Fisher Scientific (United States), Other Active Players

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: CRISPR Technology Market by Type
 4.1 CRISPR Technology Market Snapshot and Growth Engine
 4.2 CRISPR Technology Market Overview
 4.3 CRISPR Cas9
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 CRISPR Cas9: Geographic Segmentation Analysis
 4.4 CRISPR Cas12
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 CRISPR Cas12: Geographic Segmentation Analysis
 4.5 CRISPR Cas13
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 CRISPR Cas13: Geographic Segmentation Analysis

Chapter 5: CRISPR Technology Market by Application
 5.1 CRISPR Technology Market Snapshot and Growth Engine
 5.2 CRISPR Technology Market Overview
 5.3 Medical Applications
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Medical Applications: Geographic Segmentation Analysis
 5.4 Agricultural Applications
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Agricultural Applications: Geographic Segmentation Analysis
 5.5 Industrial Applications
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Industrial Applications: Geographic Segmentation Analysis
 5.6 Research Applications
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Research Applications: Geographic Segmentation Analysis

Chapter 6: CRISPR Technology Market by End-User
 6.1 CRISPR Technology Market Snapshot and Growth Engine
 6.2 CRISPR Technology Market Overview
 6.3 Biotechnology Companies
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Biotechnology Companies: Geographic Segmentation Analysis
 6.4 Pharmaceutical Companies
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Pharmaceutical Companies: Geographic Segmentation Analysis
 6.5 Academic and Research Institutions
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Academic and Research Institutions: Geographic Segmentation Analysis
 6.6 Agricultural Companies
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Agricultural Companies: Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Benchmarking
  7.1.2 CRISPR Technology Market Share by Manufacturer (2023)
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Mergers and Acquisitions
  
 7.2 CRISPR THERAPEUTICS (SWITZERLAND)
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Role of the Company in the Market
  7.2.5 Sustainability and Social Responsibility
  7.2.6 Operating Business Segments
  7.2.7 Product Portfolio
  7.2.8 Business Performance
  7.2.9 Key Strategic Moves and Recent Developments
  7.2.10 SWOT Analysis
 7.3 EDITAS MEDICINE (UNITED STATES)
 7.4 INTELLIA THERAPEUTICS (UNITED STATES)
 7.5 CARIBOU BIOSCIENCES (UNITED STATES)
 7.6 CELLECTIS (FRANCE)
 7.7 MILLIPORESIGMA (UNITED STATES)
 7.8 INTEGRATED DNA TECHNOLOGIES (UNITED STATES)
 7.9 TAKARA BIO (JAPAN)
 7.10 GENOMATIX SOFTWARE GMBH (GERMANY)
 7.11 THERMO FISHER SCIENTIFIC (UNITED STATES)
 7.12 OTHER ACTIVE PLAYERS

Chapter 8: Global CRISPR Technology Market By Region
 8.1 Overview
 8.2. North America CRISPR Technology Market
  8.2.1 Key Market Trends, Growth Factors and Opportunities
  8.2.2 Top Key Companies
  8.2.3 Historic and Forecasted Market Size by Segments
  8.2.4 Historic and Forecasted Market Size By Type
  8.2.4.1 CRISPR Cas9
  8.2.4.2 CRISPR Cas12
  8.2.4.3 CRISPR Cas13
  8.2.5 Historic and Forecasted Market Size By Application
  8.2.5.1 Medical Applications
  8.2.5.2 Agricultural Applications
  8.2.5.3 Industrial Applications
  8.2.5.4 Research Applications
  8.2.6 Historic and Forecasted Market Size By End-User
  8.2.6.1 Biotechnology Companies
  8.2.6.2 Pharmaceutical Companies
  8.2.6.3 Academic and Research Institutions
  8.2.6.4 Agricultural Companies
  8.2.7 Historic and Forecast Market Size by Country
  8.2.7.1 US
  8.2.7.2 Canada
  8.2.7.3 Mexico
 8.3. Eastern Europe CRISPR Technology Market
  8.3.1 Key Market Trends, Growth Factors and Opportunities
  8.3.2 Top Key Companies
  8.3.3 Historic and Forecasted Market Size by Segments
  8.3.4 Historic and Forecasted Market Size By Type
  8.3.4.1 CRISPR Cas9
  8.3.4.2 CRISPR Cas12
  8.3.4.3 CRISPR Cas13
  8.3.5 Historic and Forecasted Market Size By Application
  8.3.5.1 Medical Applications
  8.3.5.2 Agricultural Applications
  8.3.5.3 Industrial Applications
  8.3.5.4 Research Applications
  8.3.6 Historic and Forecasted Market Size By End-User
  8.3.6.1 Biotechnology Companies
  8.3.6.2 Pharmaceutical Companies
  8.3.6.3 Academic and Research Institutions
  8.3.6.4 Agricultural Companies
  8.3.7 Historic and Forecast Market Size by Country
  8.3.7.1 Bulgaria
  8.3.7.2 The Czech Republic
  8.3.7.3 Hungary
  8.3.7.4 Poland
  8.3.7.5 Romania
  8.3.7.6 Rest of Eastern Europe
 8.4. Western Europe CRISPR Technology Market
  8.4.1 Key Market Trends, Growth Factors and Opportunities
  8.4.2 Top Key Companies
  8.4.3 Historic and Forecasted Market Size by Segments
  8.4.4 Historic and Forecasted Market Size By Type
  8.4.4.1 CRISPR Cas9
  8.4.4.2 CRISPR Cas12
  8.4.4.3 CRISPR Cas13
  8.4.5 Historic and Forecasted Market Size By Application
  8.4.5.1 Medical Applications
  8.4.5.2 Agricultural Applications
  8.4.5.3 Industrial Applications
  8.4.5.4 Research Applications
  8.4.6 Historic and Forecasted Market Size By End-User
  8.4.6.1 Biotechnology Companies
  8.4.6.2 Pharmaceutical Companies
  8.4.6.3 Academic and Research Institutions
  8.4.6.4 Agricultural Companies
  8.4.7 Historic and Forecast Market Size by Country
  8.4.7.1 Germany
  8.4.7.2 UK
  8.4.7.3 France
  8.4.7.4 Netherlands
  8.4.7.5 Italy
  8.4.7.6 Russia
  8.4.7.7 Spain
  8.4.7.8 Rest of Western Europe
 8.5. Asia Pacific CRISPR Technology Market
  8.5.1 Key Market Trends, Growth Factors and Opportunities
  8.5.2 Top Key Companies
  8.5.3 Historic and Forecasted Market Size by Segments
  8.5.4 Historic and Forecasted Market Size By Type
  8.5.4.1 CRISPR Cas9
  8.5.4.2 CRISPR Cas12
  8.5.4.3 CRISPR Cas13
  8.5.5 Historic and Forecasted Market Size By Application
  8.5.5.1 Medical Applications
  8.5.5.2 Agricultural Applications
  8.5.5.3 Industrial Applications
  8.5.5.4 Research Applications
  8.5.6 Historic and Forecasted Market Size By End-User
  8.5.6.1 Biotechnology Companies
  8.5.6.2 Pharmaceutical Companies
  8.5.6.3 Academic and Research Institutions
  8.5.6.4 Agricultural Companies
  8.5.7 Historic and Forecast Market Size by Country
  8.5.7.1 China
  8.5.7.2 India
  8.5.7.3 Japan
  8.5.7.4 South Korea
  8.5.7.5 Malaysia
  8.5.7.6 Thailand
  8.5.7.7 Vietnam
  8.5.7.8 The Philippines
  8.5.7.9 Australia
  8.5.7.10 New Zealand
  8.5.7.11 Rest of APAC
 8.6. Middle East & Africa CRISPR Technology Market
  8.6.1 Key Market Trends, Growth Factors and Opportunities
  8.6.2 Top Key Companies
  8.6.3 Historic and Forecasted Market Size by Segments
  8.6.4 Historic and Forecasted Market Size By Type
  8.6.4.1 CRISPR Cas9
  8.6.4.2 CRISPR Cas12
  8.6.4.3 CRISPR Cas13
  8.6.5 Historic and Forecasted Market Size By Application
  8.6.5.1 Medical Applications
  8.6.5.2 Agricultural Applications
  8.6.5.3 Industrial Applications
  8.6.5.4 Research Applications
  8.6.6 Historic and Forecasted Market Size By End-User
  8.6.6.1 Biotechnology Companies
  8.6.6.2 Pharmaceutical Companies
  8.6.6.3 Academic and Research Institutions
  8.6.6.4 Agricultural Companies
  8.6.7 Historic and Forecast Market Size by Country
  8.6.7.1 Turkey
  8.6.7.2 Bahrain
  8.6.7.3 Kuwait
  8.6.7.4 Saudi Arabia
  8.6.7.5 Qatar
  8.6.7.6 UAE
  8.6.7.7 Israel
  8.6.7.8 South Africa
 8.7. South America CRISPR Technology Market
  8.7.1 Key Market Trends, Growth Factors and Opportunities
  8.7.2 Top Key Companies
  8.7.3 Historic and Forecasted Market Size by Segments
  8.7.4 Historic and Forecasted Market Size By Type
  8.7.4.1 CRISPR Cas9
  8.7.4.2 CRISPR Cas12
  8.7.4.3 CRISPR Cas13
  8.7.5 Historic and Forecasted Market Size By Application
  8.7.5.1 Medical Applications
  8.7.5.2 Agricultural Applications
  8.7.5.3 Industrial Applications
  8.7.5.4 Research Applications
  8.7.6 Historic and Forecasted Market Size By End-User
  8.7.6.1 Biotechnology Companies
  8.7.6.2 Pharmaceutical Companies
  8.7.6.3 Academic and Research Institutions
  8.7.6.4 Agricultural Companies
  8.7.7 Historic and Forecast Market Size by Country
  8.7.7.1 Brazil
  8.7.7.2 Argentina
  8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies

Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research